Increased activity of neutrophil elastase (NE), a major product of activated neutrophils, has been identified as a key risk factor for the onset and progression of bronchiectasis and lung function decline in patients with and non-CF bronchiectasis [6,7]. Here, ELANE is linked to bronchiectasis.